Project Grant R01DK141923
Award Date
9/20/24
Completion Date
7/31/29
Dollars Obligated
$643K
Federal Grant Program
93.847
Assistance Type
Project Grant
Place of Performance
Boston, MA 02215, USA
Similar Awards
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $938,470 to the University of Massachusetts Medical School to investigate a novel adipokine that may resolve non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) in mouse models. The award period runs from September 1, 2024 to June 30, 2028. The research aims...
This federal Project Grant award of $824,655 was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The funding supports research at the University of Illinois to investigate the molecular and regulatory mechanisms by which growth hormone and sex-dependent transcription factors protect the liver from metabolic dysfunction-associated steatotic liver disease...
This federal Project Grant award, funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will support research at the Pennington Biomedical Research Center to examine the role of the mitochondrial protein SLC25A25 in the onset and progression of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH)....
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $1,391,142 to Function Therapeutics Inc. to develop small molecule PAR1 ligands as a novel treatment approach for metabolic dysfunction-associated steatohepatitis (MASH). The project aims to synthesize and evaluate novel "Parmodulin" compounds that can shift PAR1 signaling in...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will support research to elucidate the functional roles of non-coding genetic variants associated with metabolic dysfunction-associated steatotic liver disease (MASLD). The $146,570 award, with a project period from January 1, 2025 to November 30, 2029, will be provided to The Trustees of the...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) provides $243,590 to the University of Chicago to study the role of the mitophagy receptor BNIP3 in regulating lipid homeostasis in the liver. The goal is to define the mechanisms by which BNIP3 decreases lipid droplet content through promoting mitophagy and lipophagy, particularly in the...
This federal Project Grant award of $675,660.00 was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award was granted to the Beth Israel Deaconess Medical Center, Inc. (Bidmc) to conduct research focused on understanding the regulation and requirements for coenzyme A (CoA) biosynthesis, and how dysregulation of CoA synthesis is related to metabolic diseases...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $172,060 to The General Hospital Corporation (doing business as Massachusetts General Hospital) to conduct research on the role of the unfolded protein response (UPR) in the pathogenesis of non-alcoholic steatohepatitis (NASH). The research aims to understand the mechanism of UPR loss...
This Project Grant award, valued at $643,700.00, was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The funding supports research by Cornell University to investigate the morphogenetic mechanisms governing the formation and function of the intestinal lymphatic smooth muscle-lacteal complex, which plays a critical role in dietary fat absorption and metabolism....
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $1,593,841 to The Children's Hospital Corporation (dba Boston Children's Hospital) to conduct research on the mechanisms that integrate type 2 diabetes (T2D) and non-alcoholic fatty liver disease (NAFLD). The research aims to investigate how hepatic insulin resistance drives the...